Drug Pipeline

Tenapanor Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
4
Phase 3
2
Top Sponsors
7
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06553547
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-05 NCT06553547
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
date change Primary completion pushed: 2026-06 -> 2026-07
2026-06-05 NCT06553547
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
date change Completion pushed: 2026-06 -> 2026-07
2026-06-05 NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric…
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-05 NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric…
date change Primary completion pushed: 2026-06-01 -> 2026-09-01
2026-06-05 NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric…
date change Completion pushed: 2026-06-01 -> 2026-09-01
2026-06-05 NCT07382167
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic…
Trial sites expanded: 79 -> 109 locations
Active Studies by Phase
Phase 3
4
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06810167 Assessing Tenapanor as a Treatment of CF-related Constipation. Cystic Fibrosis Recruiting
NCT07382167 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic… Chronic Idiopathic Constipation (CIC) Recruiting
NCT05643534 Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric… Irritable Bowel Syndrome With Constipation (IBS-C) Active, Not Recruiting
NCT05905926 Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18… Irritable Bowel Syndrome With Constipation (IBS-C) Enrolling by Invitation
Phase 2
NCT06553547 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs Irritable Bowel Syndrome With Constipation (IBS-C) Active, Not Recruiting
Sponsors Running Tenapanor Trials
Disease Areas
Get alerts when Tenapanor trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free